Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Mostrar otras versiones (1)

Due to a demonstrated lack of DNA repair deficiencies, clear cell renal cell carcinoma (ccRCC) has not benefitted from targeted synthetic lethality-based therapies. We investigated whether nucleotide excision repair (NER) deficiency is present in an identifiable subset of ccRCC cases that would rend...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosz, Aurel, Duan, Haohui, Tisza, Viktoria, Sahgal, Pranshu, Topka, Sabine, Klus, Gregory T., Börcsök, Judit, Sztupinszki, Zsofia, Hanlon, Timothy, Diossy, Miklos, Vizkeleti, Laura, Stormoen, Dag Rune, Csabai, Istvan, Pappot, Helle, Vijai, Joseph, Offit, Kenneth, Ried, Thomas, Sethi, Nilay, Mouw, Kent W., Spisak, Sandor, Pathania, Shailja, Szallasi, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667362/
https://www.ncbi.nlm.nih.gov/pubmed/37996508
http://dx.doi.org/10.1038/s41598-023-47946-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667362/
https://www.ncbi.nlm.nih.gov/pubmed/37996508
http://dx.doi.org/10.1038/s41598-023-47946-4

Ejemplares similares